Beclate 200mcg Inhaler is a corticosteroid medication used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). Available in both inhaler (MDI) and capsule form, it helps reduce inflammation, swelling, and irritation in the airways, making breathing easier and preventing asthma attacks.

• Inhaler (MDI): Delivers Beclometasone directly to the lungs for fast, targeted anti-inflammatory action.

• Capsule: Provides an oral option for patients who prefer non-inhaled medication, offering systemic anti-inflammatory effects.

This medicine is ideal for patients with moderate to severe asthma, chronic bronchitis, or COPD who require consistent symptom control and prevention of flare-ups. Beclate 200mcg Inhaler is clinically proven to improve lung function, reduce wheezing, and minimize the risk of exacerbations.